{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-123758","form_type":"8-K","ticker":"IKT","cik":"0001750149","company_name":"Inhibikase Therapeutics, Inc.","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.881176+00:00","generated_at":"2026-06-03T04:35:27.049339+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Inhibikase receives arbitration demand for $1.625M from Pivot over milestone payments","bullets":["Pivot Holding LLC, successor to Sphaera Pharma, demands $1.625 million plus interest for alleged breach of 2012 collaboration agreement.","Company believes claims are without merit and will vigorously dispute; intends to assert counterclaims.","Arbitration proceeding administrated by American Arbitration Association; no timeline for resolution disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-123758","json":"https://secwatch.observer/filing/0001193125-24-123758.json","markdown":"https://secwatch.observer/filing/0001193125-24-123758.md","text":"https://secwatch.observer/filing/0001193125-24-123758.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750149/000119312524123758/0001193125-24-123758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750149/000119312524123758/d827800d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T04:35:27.049339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}